BSE filing, NSE: IOB. Summary written from the filing by ALFA Finder's alert engine.
Indian Overseas Bank: key numbers
- Share price
- ₹29.10
- Market cap
- ₹56,037 Cr
- Revenue (annual)
- ₹31,896 Cr
- Net profit (annual)
- ₹5,418 Cr
- P/E (TTM)
- 8.4×Sector 19.7×
- Promoter holding
- 92.44%+0.00% QoQ
- FII holding
- 0.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indian Overseas Bank
All →Indian Overseas Bank Management Change
Indian Overseas Bank's board appointed Mr. Akshit Choudhary as Chief Financial Officer effective 1 November 2026, replacing Mr. Madhaw Chandra Jha. The filing includes his brief profile and the required LODR disclosures.
Indian Overseas Bank Investor Presentation: Key Takeaways
Q2 FY27 net profit Rs1,912 Cr, up 55.95% YoY and 15.25% QoQ. NII Rs3,867 Cr (+26.41% YoY). ROE 24.58%, ROA 1.53%, GNPA 1.19%.
Indian Overseas Bank Results Update
IOB's net profit jumped 55.95% YoY to ₹1,912 Crore in Q2 FY27, with operating profit rising 25.67% to ₹3,016 Crore. NII grew 26.41% and NPA ratios continued to improve.
Indian Overseas Bank Q2 FY27 Results: Net Profit ₹1,963 Cr, Up 55.9% YoY
Indian Overseas Bank reported revenue from operations of ₹9,201 Cr (+17.2% YoY) and net profit of ₹1,963 Cr (+55.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,963 Cr · +55.9% YoY
Indian Overseas Bank Business Update
Indian Overseas Bank disclosed RBI findings on understated risk weights for some exposures. It states no net profit impact, with CRAR remaining well above minimums.
Indian Overseas Bank Other Announcement
The filing presents the shareholding pattern of Indian Overseas Bank for the quarter ended September 30, 2026. No material transaction is reported.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date